PAS Post-Graduate Course: Neo ROP: You Saved the Baby, But Can We Save The Sight?

Friday, April 25, 2025

7:00am – 1:30pm HST

Location: Convention Center: 305

CE: 5.5

Chair(s)

Faizah Bhatti, MD, MS (she/her/hers)

Associate Professor
Oklahoma Childrens Hospital at OU Health
Oklahoma City, Oklahoma, United States
AC

Alison Chu, MD

University of California, Los Angeles David Geffen School of Medicine
Los Angeles, California, United States

Disclosure(s):

Faizah Bhatti, MD, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Alison Chu, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Retinopathy of Prematurity (ROP), even of low grade which has regressed, is a lifelong disease with major quality of life implications for our preterm population. This postgraduate course is designed to engage residents, fellows, faculty and any other interested individuals and to discuss the etiology, science, and clinical practices related to ROP. Our multi-disciplinary faculty will cover the etiological, neonatal, retinal screening and ophthalmological facets of the disease with participation form experts who will delve into global practices and neurodevelopmental associations of this disease. We will introduce a multi-disciplinary curriculum including national and international clinical and science neonatal ROP experts along with ophthalmology colleagues who study and treat ROP and develop tech/AI. We will guide attendees to use this knowledge in probing related scientific questions and explore the critical gaps in knowledge we need to address to improve outcomes.

Learning Objectives:

Understand pathophysiology of vascular dysgenesis with application to vasoobliteration and neovascular disease in ROP. Discuss current standard of care treatments understanding potential limitations and/or complications.
Adapt clinical practices to address the short- and long-term implications and lifelong complications related to ROP from a visual, neurodevelopmental, and global standpoint.
Apply knowledge of current screening practices, technologies and future in diagnosis of ROP. To begin design and implementation of successful Tele-ROP programs.

Presentations:

7:00am – 7:10am HST

Welcome and Introductions Session 1
Speaker: Faizah Bhatti, MD, MS (she/her/hers) – Oklahoma Childrens Hospital at OU Health
Speaker: Alison Chu, MD – University of California, Los Angeles David Geffen School of Medicine
7:10am – 7:50am HST

Origin Story: Angiogenesis, Inflammation and ROP. How Do We rescue Vascular Arrest?
Speaker: Faizah Bhatti, MD, MS (she/her/hers) – Oklahoma Childrens Hospital at OU Health
7:50am – 8:35am HST

Insights from Basic Science and Translation to Clinical Treatment of ROP
Speaker: Mary Elizabeth Hartnett, MD, FACS, FARVO (she/her/hers) – Stanford University School of Medicine
8:35am – 9:05am HST

The Role of Nutrition in ROP
Speaker: Alison Chu, MD – University of California, Los Angeles David Geffen School of Medicine
9:05am – 9:20am HST

PANEL DISCUSSION: The Great Debate- to Avastin or Not to Avastin?
Speaker: Mary Elizabeth Hartnett, MD, FACS, FARVO (she/her/hers) – Stanford University School of Medicine
Speaker: Faizah Bhatti, MD, MS (she/her/hers) – Oklahoma Childrens Hospital at OU Health
Speaker: J. Peter Campbell, MD, MPH (he/him/his) – Oregon Health & Science University School of Medicine
Speaker: Alison Chu, MD – University of California, Los Angeles David Geffen School of Medicine
9:35am – 9:40am HST

Welcome and Introductions Session 2
Speaker: Alison Chu, MD – University of California, Los Angeles David Geffen School of Medicine
9:40am – 10:10am HST

Critical Gaps in Knowledge: Who to Screen for ROP
Speaker: Jeffrey Shenberger, MD (he/him/his) – Connecticut Children's Medical Center
10:10am – 10:45am HST

Developments in Retinal Screening, Imaging and AI Informatics
Speaker: J. Peter Campbell, MD, MPH (he/him/his) – Oregon Health & Science University School of Medicine
10:45am – 11:05am HST

Building and Implementing ROP Telemedicine Screening Programs
Speaker: Abhishek Makkar, MD (he/him/his) – University of Texas Southwestern Medical School
11:05am – 11:20am HST

PANEL DISCUSSION: Screening Programs and Partnerships Between Neonatology and Ophthalmology
Speaker: Abhishek Makkar, MD (he/him/his) – University of Texas Southwestern Medical School
Speaker: J. Peter Campbell, MD, MPH (he/him/his) – Oregon Health & Science University School of Medicine
11:20am – 12:15pm HST

Lunch
12:05pm – 12:25pm HST

Visuopathy of Prematurity: Inflammation, ROP, and the Brain
Speaker: Olaf Dammann, SM, MD, PhD (he/him/his) – Tufts University School of Medicine
12:15pm – 1:05pm HST

Welcome and Introductions Session 3
Speaker: Faizah Bhatti, MD, MS (she/her/hers) – Oklahoma Childrens Hospital at OU Health
12:25pm – 1:05pm HST

Global Perspectives of ROP: From Prevention to Follow-up
Speaker: Brian A. Darlow, MB BChir MD (he/him/his) – University of Otago Christchurch New Zealand
1:05pm – 1:20pm HST

PANEL DISCUSSION: ROP Across the Lifespan, Co-morbidities and Under Investigated Facets of the Disease
Speaker: Brian A. Darlow, MB BChir MD (he/him/his) – University of Otago Christchurch New Zealand
Speaker: Jeffrey Shenberger, MD (he/him/his) – Connecticut Children's Medical Center
1:20pm – 1:30pm HST

Concluding Discussion